Edition:
United States

Cardiovascular Systems Inc (CSII.O)

CSII.O on Nasdaq

27.81USD
24 Feb 2017
Change (% chg)

$0.17 (+0.62%)
Prev Close
$27.64
Open
$27.45
Day's High
$28.01
Day's Low
$27.43
Volume
179,919
Avg. Vol
291,647
52-wk High
$29.70
52-wk Low
$7.50

Latest Key Developments (Source: Significant Developments)

Cardiovascular Systems reports Q2 earnings per share $0.03
Wednesday, 25 Jan 2017 04:05pm EST 

Cardiovascular Systems Inc : Reports fiscal 2017 second-quarter financial results . Q2 earnings per share $0.03 . Q2 revenue $50 million versus I/B/E/S view $49.6 million . Sees Q3 2017 loss per share $0.04 to $0.06 . Sees Q3 2017 revenue $50.5 million to $51.5 million . Q2 earnings per share view $-0.06 -- Thomson Reuters I/B/E/S .Q3 earnings per share view $-0.05, revenue view $51.9 million -- Thomson Reuters I/B/E/S.  Full Article

Cardiovascular Systems Inc signs distribution agreement with Medikit Co., Ltd
Monday, 14 Nov 2016 06:00am EST 

Cardiovascular Systems Inc : Agreement includes $10 million upfront payment to CSI .Press release - Cardiovascular systems, Inc. signs distribution agreement with Medikit Co., Ltd. for Japan.  Full Article

Cardiovascular Systems names Scott Ward as CEO
Tuesday, 16 Aug 2016 07:00am EDT 

Cardiovascular Systems Inc : Cardiovascular Systems names Scott Ward as CEO . Cardiovascular Systems Inc says Scott R. Ward, company's new chairman and chief executive officer, effective immediately .Scott Ward has been serving as chairman since November 2014 and interim president and CEO since November 2015.  Full Article

Cardiovascular Systems reports Q4 loss per share $0.15
Wednesday, 3 Aug 2016 04:05pm EDT 

Cardiovascular Systems Inc : Q4 revenue $48.5 million versus I/B/E/S view $46 million . Q4 earnings per share view $-0.20 -- Thomson Reuters I/B/E/S . Quarter financial results . Q4 loss per share $0.15 . Sees q1 revenue in a range of $48.0 million to $49.5 million . Sees q1 loss per common share ranging from $0.18 to $0.21 .Q1 earnings per share view $-0.22, revenue view $45.9 million -- Thomson Reuters I/B/E/S.  Full Article

Cardiovascular Systems announces settlement agreement to resolve investigation by DOJ, qui tam complaint filed by Travis Thams
Tuesday, 28 Jun 2016 05:01pm EDT 

Cardiovascular Systems Inc : Settlement agreement with United States of America, to resolve investigation by DOJ, qui tam complaint filed by Travis Thams . Under the settlement agreement, the company will pay $8 million - SEC filing .Will also be required to pay Thams' reasonable expenses, costs and attorney’s fees, which amount has not yet been determined.  Full Article

Class Action Lawsuit Filed Against Cardiovascular Systems Inc - ACSWIR
Monday, 21 Mar 2016 09:02am EDT 

Cardiovascular Systems Inc:The law firm of Kessler Topaz Meltzer & Check, LLP announces that it has filed a shareholder class action lawsuit in the United States District Court for the District of Minnesota against Cardiovascular Systems - ACSWIR.on behalf of purchasers of the Company's common stock between September 12, 2011 and January 21, 2016, inclusive (the "Class Period").The shareholder class action complaint alleges that CSI and certain of its executive officers made a series of false and misleading statements and failed to disclose material adverse facts about the Company's business and operations.Specifically, the defendants are alleged to have falsely touted CSI's code of ethics while failing to disclose that the Company relied upon illegal kickbacks, off-label promotions, and other violations of applicable laws and regulations in order to drive sales of its products.  Full Article

Cardiovascular Systems Inc gives Q3 2016 guidance
Thursday, 21 Jan 2016 04:05pm EST 

Cardiovascular Systems Inc:Anticipates Q3 2016 Revenue in a range of $40.5 million to $42 million.Anticipates Q3 2016 Net loss in the range of $(13.7) million to $(14.6) million, or loss per common share ranging from $(0.42) to $(0.45).  Full Article

Cardiovascular Systems Inc CEO to Take Medical Leave
Monday, 16 Nov 2015 04:05pm EST 

Cardiovascular Systems Inc:CEO to take medical leave.Says Scott ward, currently chairman of board, will serve as chairman and interim chief executive officer.Effective December 1, CEO David L. Martin will take medical leave of absence for about three months to focus on cancer treatment.  Full Article

Cardiovascular Systems Inc gives Q2 2016 guidance below analysts' estimates
Wednesday, 4 Nov 2015 04:05pm EST 

Cardiovascular Systems Inc:Sees Q2 2016 revenue in a range of $42.5 million to $44.0 million.Sees Q2 2016 Net loss in the range of $(15.8) million to $(16.7) million, or loss per common share ranging from $(0.49) to $(0.51).Q2 2016 revenue of $46.1 million and EPS of $(0.34) - Thomson Reuters I/B/E/S.  Full Article

Cardiovascular Systems Inc lowers Q1 2016 guidance
Wednesday, 7 Oct 2015 04:00pm EDT 

Cardiovascular Systems Inc:Expects Q1 2016 revenues of about $43.9 million.Says Q1 2016 net loss is anticipated to be in the range of $(13.1) million to $(13.9) million, or $(0.41) to $(0.43) per common share.Q1 2016 revenue of $49.4 million, net income of $(12.4) million and EPS of $(0.39) - Thomson Reuters I/B/E/S.  Full Article

More From Around the Web

BRIEF-Cardiovascular Systems says Martha Goldberg Aronson joins board

* Cardiovascular systems announces healthcare veteran Martha Goldberg Aronson joins board of directors Source text for Eikon: Further company coverage: